학술논문
UK AMD EMR USERS GROUP REPORT V: Benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12
Document Type
Article
Author
Lee, A.Y.; Egan, C.; Keane, P.A.; Sim, D.; Bunce, C.; Tufail, A.; Lee, C.S.; Butt, T.; Xing, W.; Johnston, R.L.; Chakravarthy, U.; Akerele, T.; McKibbin, M.; Downey, L.; Natha, S.; Bailey, C.; Khan, R.; Antcliff, R.; Varma, A.; Kumar, V.; Tsaloumas, M.; Mandal, K.; Liew, G.; Armstrong, S.; Cazabon, J.; Mohamed, Q.; Sallam, A.; Zarranz-Ventura Hull, J.; Arora, S.; Cook, H.; Gopalakrishnan, K.; Lyon, F.; Islam, T.; Zaman, N.; Backhouse, O.; Dabbs, T.; Davies, B.; Mokete, B.; O'Neill, D.; Patel, P.J.
Source
In: British Journal of Ophthalmology . (British Journal of Ophthalmology, 1 August 2015, 99(8):1045-1050)
Subject
Language
English
ISSN
14682079
00071161
00071161